Related references
Note: Only part of the references are listed.Saposin C is a frequent target of paraproteins in Gaucher disease-associated MGUS/multiple myeloma
Klaus-Dieter Preuss et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Glucosylsphingosine is a reliable response biomarker in Gaucher disease
David Arkadir et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Hepatocellular carcinoma in Gaucher disease: an international case series
Martine Regenboog et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Jerome Stirnemann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12 372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey
O. Landgren et al.
BLOOD CANCER JOURNAL (2017)
Glucosylsphingosine is a key biomarker of Gaucher disease
Vagishwari Murugesan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma
Shiny Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Gaucher disease and comorbidities: B-cell malignancy and parkinsonism
Timothy M. Cox et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation
Shiny Nair et al.
BLOOD (2015)
Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature
Maarten Arends et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients
Jerome Stirnemann et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Gaucher disease and dysgammaglobulinemia: A report of 61 patients, including 18 with GD type III
Agnieszka Jurecka et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
The incidence of Parkinsonism in patients with type 1 Gaucher disease: Data from the ICGG Gaucher Registry
Barry Rosenbloom et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients
Tamar H. Taddei et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Gaucher disease and monoclonal gammopathy: A report of 17 cases and impact of therapy
Bernard Grosbois et al.
BLOOD CELLS MOLECULES AND DISEASES (2009)
IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: A case report
C. Martinez-Redondo et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature
M. de Fost et al.
ANNALS OF HEMATOLOGY (2008)
Hyperimmunoglobulinemia in pediatric-onset type 1 Gaucher disease and effects of enzyme replacement therapy
Eytan Wine et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2007)
Risk of malignant disease among 1525 adult male US veterans with gaucher disease
Ola Landgren et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Prevalence of monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Increased incidence of cancer in adult Gaucher disease in Western Europe
M de Fost et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
Gaucher disease: complexity in a simple disorder
E Sidransky
MOLECULAR GENETICS AND METABOLISM (2004)
Effect of enzyme replacement therapy on gammopathies in Gaucher disease
A Brautbar et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Retrospective cohort study of 148 patients with polyclonal gammopathy
A Dispenzieri et al.
MAYO CLINIC PROCEEDINGS (2001)
Share Paper
